Results 231 to 240 of about 183,897 (254)

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

Immunity, 2019
Jennifer Abelin, Joel Greshock, Jeffrey Hammerbacher   +2 more
exaly  

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Blood, 2007
Daniel Weisdorf, Carolyn Hurley, Effie Petersdorf   +2 more
exaly  

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules

Journal of Experimental Medicine, 1996
Lisa Denzin, Peter Cresswell, Cresswell Peter   +2 more
exaly  

HLA-E BINDING

1999
BRAUD VERONIQUE M, ALLAN DAVID S J, OGG GRAHAM S, O'CALLAGHAN CHRISTOPHER A, MCMICHAEL ANDREW J   +4 more
openaire   +4 more sources

Definitive class I human leukocyte antigen expression in gestational placentation: HLA ‐F, HLA ‐E, HLA ‐C, and HLA ‐G in extravillous trophoblast invasion on placentation, pregnancy, and parturition

American Journal of Reproductive Immunology, 2017
Stephen Lye, Caroline Dunk
exaly  

35-OR: NK cell activation is dependent on HLA-E surface expression and the peptide presented by HLA-E

Human Immunology, 2011
Nina Lauterbach, Lotte Wieten, Laura van Zon, Christina E.M. Voorter, Marcel G.J. Tilanus   +4 more
openaire   +1 more source

Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Journal of Experimental Medicine, 1992
Parham P
exaly  

HLA-E chimeric molecule

2005
MIYAGAWA SHUJI, MATSUNAMI KATSUYOSHI
openaire   +2 more sources

Population genetic studies of HLA-E

Human Immunology, 1997
Carrie Grimsley, Carole Ober
openaire   +1 more source

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

Lancet, The, 2002
D Maxwell, F T Christiansen, I James
exaly